DXCM DexCom, Inc.
Stock · NasdaqGS · United States · Healthcare · US2521311074
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by DexCom, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD.
Updated 06 Nov 2026 15:58. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 17 Jun 2025 | 82.67 | 83.35 | 81.61 | 81.83 | -1.41% | 2,685,600 | |
| 16 Jun 2025 | 82.80 | 83.70 | 82.27 | 83.00 | +1.23% | 3,446,200 | |
| 13 Jun 2025 | 81.69 | 83.17 | 81.39 | 81.99 | -1.04% | 2,904,100 | |
| 12 Jun 2025 | 83.09 | 83.61 | 82.02 | 82.85 | -0.17% | 2,805,300 | |
| 11 Jun 2025 | 85.01 | 85.49 | 82.90 | 82.99 | -2.16% | 3,246,300 | |
| 10 Jun 2025 | 86.05 | 86.45 | 84.31 | 84.82 | -1.00% | 2,246,900 | |
| 09 Jun 2025 | 86.91 | 86.94 | 85.09 | 85.68 | -1.14% | 2,072,800 | |
| 06 Jun 2025 | 86.73 | 87.91 | 85.83 | 86.67 | +1.08% | 2,422,600 | |
| 05 Jun 2025 | 85.78 | 86.54 | 84.87 | 85.74 | +0.15% | 2,394,700 | |
| 04 Jun 2025 | 86.87 | 87.24 | 85.59 | 85.61 | -1.36% | 1,858,000 | |
| 03 Jun 2025 | 85.49 | 87.33 | 84.50 | 86.79 | +1.50% | 2,423,000 | |
| 02 Jun 2025 | 85.44 | 85.88 | 84.10 | 85.51 | -0.34% | 2,524,300 | |
| 30 May 2025 | 86.76 | 86.80 | 84.85 | 85.80 | +1.11% | 4,257,100 | |
| 29 May 2025 | 87.65 | 87.67 | 84.51 | 84.86 | -2.44% | 3,694,200 | |
| 28 May 2025 | 85.24 | 87.60 | 85.24 | 86.98 | +1.93% | 2,862,700 | |
| 27 May 2025 | 85.44 | 85.70 | 84.60 | 85.33 | +0.97% | 2,034,100 | |
| 23 May 2025 | 83.94 | 85.01 | 83.48 | 84.51 | -0.38% | 2,599,300 | |
| 22 May 2025 | 84.90 | 85.31 | 84.28 | 84.83 | -0.07% | 1,693,900 | |
| 21 May 2025 | 86.43 | 87.00 | 84.50 | 84.89 | -2.81% | 2,673,200 | |
| 20 May 2025 | 86.21 | 87.65 | 85.88 | 87.34 | +0.44% | 2,743,300 | |
| 19 May 2025 | 84.67 | 86.99 | 84.34 | 86.96 | +1.73% | 2,366,300 | |
| 16 May 2025 | 85.88 | 86.00 | 84.68 | 85.48 | -0.22% | 3,397,900 | |
| 15 May 2025 | 86.21 | 86.85 | 84.76 | 85.67 | -0.98% | 2,892,200 | |
| 14 May 2025 | 83.64 | 86.57 | 83.64 | 86.52 | +2.87% | 3,828,400 | |
| 13 May 2025 | 84.74 | 85.54 | 83.84 | 84.11 | -1.11% | 5,514,200 |
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
Key data
- Previous close
- 84.46 USD
- Market cap
- 33.0B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Devices
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 25.0 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 23.0 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 19.5 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 8.1 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 10.0 / 10 |
|
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A).
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 33.25× | Weak | 32.71× |
| P/E (forward) | 26.94× | Weak | 15.76× |
| Price / book | 12.43× | Weak | 3.74× |
| Price / sales | 6.17× | Weak | 3.52× |
| EV / EBITDA | 21.73× | Weak | 13.54× |
| Free cash flow yield | 2.6% | Fair | 3% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 63.4% | Good | 66.1% |
| Operating margin | 24.3% | Good | 8% |
| Net margin | 19.4% | Good | 3.5% |
| Return on equity | 37.7% | Good | 6.4% |
| Return on assets | 11.1% | Good | 3.9% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 17% | Good | 10.5% |
| EPS growth / year | 36.6% | Good | 7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.55× | Good | 0.52× |
| Net debt / EBITDA | -0.28× | Good | 1.62× |
| Interest cover | 49.83× | Good | 3.3× |
| Current ratio | 1.74× | Good | 2.12× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow DXCM and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.